My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 3055

    1.

    Increased plasma amylin in type 1 diabetic patients after kidney and pancreas transplantation: A sign of impaired beta-cell function?

    Stadler M, Anderwald C, Karer T, Tura A, Kästenbauer T, Auinger M, Bieglmayer C, Wagner O, Kronenberg F, Nowotny P, Pacini G, Prager R.

    Diabetes Care. 2006 May;29(5):1031-8.PMID: 16644633 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Changes in amylin and amylin-like peptide concentrations and beta-cell function in response to sulfonylurea or insulin therapy in NIDDM.

    Rachman J, Payne MJ, Levy JC, Barrow BA, Holman RR, Turner RC.

    Diabetes Care. 1998 May;21(5):810-6.PMID: 9589246 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Normalization of insulin sensitivity and glucose homeostasis in type I diabetic pancreas transplant recipients: a 48-month cross-sectional study--a clinical research center study.

    Cottrell DA.

    J Clin Endocrinol Metab. 1996 Oct;81(10):3513-9.PMID: 8855794 [PubMed - indexed for MEDLINE]Related articles

    4.

    Insulin secretion, insulin action and non-insulin-dependent glucose uptake in pancreas transplant recipients.

    Christiansen E, Tibell A, Võlund A, Rasmussen K, Tydén G, Pedersen O, Christensen NJ, Madsbad S.

    J Clin Endocrinol Metab. 1994 Dec;79(6):1561-9.PMID: 7989456 [PubMed - indexed for MEDLINE]Related articles

    5.

    Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

    Diabetes Care. 1998 Jan;21(1):76-9.PMID: 9538973 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Determinants of a normal (versus impaired) oral glucose tolerance after combined pancreas-kidney transplantation in IDDM patients.

    Pfeffer F, Nauck MA, Benz S, Gwodzinski A, Zink R, Büsing M, Becker HD, Hopt UT.

    Diabetologia. 1996 Apr;39(4):462-8.PMID: 8777996 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.

    Greenbaum CJ, Prigeon RL, D'Alessio DA.

    Diabetes. 2002 Apr;51(4):951-7.PMID: 11916912 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Plasma islet amyloid polypeptide (Amylin) levels and their responses to oral glucose in type 2 (non-insulin-dependent) diabetic patients.

    Sanke T, Hanabusa T, Nakano Y, Oki C, Okai K, Nishimura S, Kondo M, Nanjo K.

    Diabetologia. 1991 Feb;34(2):129-32.PMID: 2065848 [PubMed - indexed for MEDLINE]Related articles

    9.

    Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus--"Flatbush diabetes".

    Banerji MA.

    J Pediatr Endocrinol Metab. 2002 Apr;15 Suppl 1:493-501. Review.PMID: 12017222 [PubMed - indexed for MEDLINE]Related articles

    10.

    Physiological and pharmacological stimulation of pancreatic islet hormone secretion in type I diabetic pancreas allograft recipients.

    Osei K, Henry ML, O'Dorisio TM, Tesi RJ, Sommer BG, Ferguson RM.

    Diabetes. 1990 Oct;39(10):1235-42.PMID: 2210076 [PubMed - indexed for MEDLINE]Related articles

    11.

    Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.

    Cretti A, Lehtovirta M, Bonora E, Brunato B, Zenti MG, Tosi F, Caputo M, Caruso B, Groop LC, Muggeo M, Bonadonna RC.

    Eur J Clin Invest. 2001 May;31(5):405-16.PMID: 11380592 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improved glycemic control and enhanced insulin sensitivity in type 2 diabetic subjects treated with pioglitazone.

    Miyazaki Y, Mahankali A, Matsuda M, Glass L, Mahankali S, Ferrannini E, Cusi K, Mandarino LJ, DeFronzo RA.

    Diabetes Care. 2001 Apr;24(4):710-9.PMID: 11315836 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Simple empirical assessment of beta-cell function by a constant infusion of glucose test in normal and type 2 (non-insulin-dependent) diabetic subjects.

    Levy JC, Rudenski A, Burnett M, Knight R, Matthews DR, Turner RC.

    Diabetologia. 1991 Jul;34(7):488-99.PMID: 1916054 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.

    Amoah AG, Owusu SK, Schuster DP, Osei K.

    S Afr Med J. 2002 May;92(5):377-84.PMID: 12108171 [PubMed - indexed for MEDLINE]Related articles

    15.

    Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients.

    Luzi L, Groop LC, Perseghin G, Taskinen MR, Hilden H, Bianchi E, Terruzzi I, Dodesini AR, Di Carlo V, Pozza G.

    Diabetes. 1996 Mar;45(3):354-60.PMID: 8593942 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.

    Knowles NG, Landchild MA, Fujimoto WY, Kahn SE.

    Diabetes Care. 2002 Feb;25(2):292-7.PMID: 11815498 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Reduced amylin release is a characteristic of impaired glucose tolerance and type 2 diabetes in Japanese Americans.

    Kahn SE, Verchere CB, Andrikopoulos S, Asberry PJ, Leonetti DL, Wahl PW, Boyko EJ, Schwartz RS, Newell-Morris L, Fujimoto WY.

    Diabetes. 1998 Apr;47(4):640-5.PMID: 9568698 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Improved postprandial metabolic control after subcutaneous injection of a short-acting insulin analog in IDDM of short duration with residual pancreatic beta-cell function.

    Pampanelli S, Torlone E, Ialli C, Del Sindaco P, Ciofetta M, Lepore M, Bartocci L, Brunetti P, Bolli GB.

    Diabetes Care. 1995 Nov;18(11):1452-9.PMID: 8722069 [PubMed - indexed for MEDLINE]Related articles

    19.

    Islet amyloid polypeptide (IAPP) secretion from islet cells and its plasma concentration in patients with non-insulin-dependent diabetes mellitus.

    Hanabusa T, Kubo K, Oki C, Nakano Y, Okai K, Sanke T, Nanjo K.

    Diabetes Res Clin Pract. 1992 Jan;15(1):89-96.PMID: 1541240 [PubMed - indexed for MEDLINE]Related articles

    20.

    Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.

    Gottsäter A, Landin-Olsson M, Fernlund P, Lernmark A, Sundkvist G.

    Diabetes Care. 1993 Jun;16(6):902-10.PMID: 8325204 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity